4/22
08:30 am
mbot
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
Low
Report
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
4/14
02:30 pm
mbot
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
Low
Report
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
4/14
08:00 am
mbot
Microbot Medical (MBOT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Microbot Medical (MBOT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.
4/13
08:30 am
mbot
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
Low
Report
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
4/13
06:01 am
mbot
Microbot Medical (MBOT) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Low
Report
Microbot Medical (MBOT) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
3/26
08:30 am
mbot
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
Medium
Report
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
3/24
08:30 am
mbot
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
Low
Report
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
3/17
09:05 am
mbot
Microbot Medical® to Participate at the 38th Annual Roth Conference [Yahoo! Finance]
Low
Report
Microbot Medical® to Participate at the 38th Annual Roth Conference [Yahoo! Finance]
3/17
08:40 am
mbot
Microbot Medical® to Participate at the 38th Annual Roth Conference
Low
Report
Microbot Medical® to Participate at the 38th Annual Roth Conference
3/10
08:59 am
mbot
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time [Yahoo! Finance]
Low
Report
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time [Yahoo! Finance]
3/10
08:30 am
mbot
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
Low
Report
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
3/4
08:43 am
mbot
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation [Yahoo! Finance]
Low
Report
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation [Yahoo! Finance]
3/4
08:30 am
mbot
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
Low
Report
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
3/3
09:39 am
mbot
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event [Yahoo! Finance]
Low
Report
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event [Yahoo! Finance]
3/3
09:00 am
mbot
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
Low
Report
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
2/24
08:30 am
mbot
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
High
Report
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
2/19
08:30 am
mbot
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
Medium
Report
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
2/14
06:24 am
mbot
Microbot Medical (NASDAQ:MBOT) was upgraded by analysts at B.Riley Securit to a "strong-buy" rating.
Medium
Report
Microbot Medical (NASDAQ:MBOT) was upgraded by analysts at B.Riley Securit to a "strong-buy" rating.
2/12
08:30 am
mbot
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
Medium
Report
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
2/10
08:12 am
mbot
Microbot Medical (NASDAQ:MBOT) is now covered by analysts at B. Riley Securities. They set a "buy" rating and a $5.00 price target on the stock.
Neutral
Report
Microbot Medical (NASDAQ:MBOT) is now covered by analysts at B. Riley Securities. They set a "buy" rating and a $5.00 price target on the stock.
2/10
06:02 am
mbot
Microbot Medical (NASDAQ:MBOT) is now covered by analysts at B. Riley Financial, Inc.. They set a "buy" rating on the stock.
Medium
Report
Microbot Medical (NASDAQ:MBOT) is now covered by analysts at B. Riley Financial, Inc.. They set a "buy" rating on the stock.
2/5
08:30 am
mbot
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
Medium
Report
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption